RE: Depending on your average shareprice is how you interpret the RTO14 May 2024 16:00
Agneissearner -
14. Adoption of New Name and Articles
It is proposed that the name of the Company be changed to CRISM Therapeutics Corporation (the “New
Name”), that an application to so change the Company's name shall be filed with the BVI Registrar, that the
number of shares that the Company is authorised to issue be increased from 2,000,000,000 to
16,000,000,000 (the “Initial Share Increase”) and that the New Articles be adopted.
The purpose of the Initial Share Increase is to create additional authorised shares to permit the issuance of
shares and to facilitate, if approved, achieving a position where the ultimate number of authorised shares is
100,000,000 following the Share Consolidation.